# Gemcitabine With Ascorbate Including Adolescents

> **NCT04877587** · EARLY_PHASE1 · WITHDRAWN · sponsor: **David Dickens**

## Conditions studied

- Soft Tissue Sarcoma
- Bone Sarcoma
- Unresectable Soft Tissue Sarcoma
- Metastatic Bone Sarcoma
- Metastatic Soft-tissue Sarcoma
- Unresectable Bone Sarcoma

## Interventions

- **DRUG:** Ascorbate
- **DRUG:** Gemcitabine

## Key facts

- **NCT ID:** NCT04877587
- **Lead sponsor:** David Dickens
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2023-01
- **Primary completion:** 2025-05-31
- **Final completion:** 2025-05-31
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Unable to enroll
- **Last updated:** 2023-02-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04877587

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04877587, "Gemcitabine With Ascorbate Including Adolescents". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04877587. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*